[Skip to Content]
[Skip to Content Landing]
Views 547
Citations 0
Comment & Response
November 26, 2014

Costs of New Treatments for Hepatitis C Infection

Author Affiliations
  • 1Cedars-Sinai Medical Care Foundation, Beverly Hills, California
JAMA. 2014;312(20):2168. doi:10.1001/jama.2014.14343

To the Editor Drs Brennan and Shrank1 raised several important questions regarding the imperative of balancing individual and societal benefits of certain new medications against their large financial expense. Equitable return on investment is commonly deemed acceptable; however, defining a reasonable standard for return on investment requires appropriate and complete information.

First Page Preview View Large
First page PDF preview
First page PDF preview
×